© Copyright Nostre Net
The global insulin delivery devices market is relied upon to enroll CAGR and is foreseen hit USD 31445.06 Million by 2030,. Insulin, a glucose directing hormone, assumes a fundamental job in the whole treatment of diabetes. Insulin delivery frameworks help in infusing insulin into the greasy tissue under the skin. Factors, such as developing diabetic populace, innovative headways in insulin delivery systems, and favoring repayment arrangements, expanding mindfulness among shoppers on the accessibility of a few delivery devices and advancement of human insulin devices are relied upon to positively affect the insulin delivery devices. However, the accessibility of oral insulin as an elective medication delivery technique is probably going to hamper the development of the insulin delivery devices market. Expanding awareness about diabetic consideration is among the drivers for the market.
Medtronic Recalls MiniMed Insulin Pumps for Potential Cybersecurity Risks the FDA has distinguished this as a Class I review, the most genuine sort of review. Utilization of these devices may cause genuine wounds or demise The review portrayed in this notice is a similar one that was reported in the FDA Safety Communication from June 27, 2019. Different factors that are driving the worldwide Insulin delivery devices market are developing appropriation of self-injectable devices and expanding FDA endorsements for tranquilize delivery devices.
Competitive Analysis:
Some of the major companies in the global Insulin Delivery Devices Market include Novo Nordisk A/S, Becton, Dickinson and Company, Medtronic PLC, Eli Lilly, Sanofi, Johnson and Johnson, Biocon Limited, Tandem Diabetes Care, Inc., B. Braun Melsungen AG, and F. Hoffmann-La Roche.
Segmentation:
The global insulin delivery devices market, based on type, is segmented into insulin syringes, pen, pumps, insulin jet injectors, pen needles, and others. The pen segment is further sub-segmented into reusable insulin pens and disposable insulin pens. The pumps segment is further sub-segmented into external/tethered pumps smart insulin patch and patch pumps. The pen segment comprises standard pen needles and safety pen needles.
Based on the distribution channel, the global insulin delivery devices market is segmented into hospital pharmacy, retail pharmacy, online sales, and diabetes clinics/centers.
Based on end user, the global insulin delivery devices market is segmented into hospitals & clinics, home care, and specialty centers.
Regional Analysis:
Regionally, the Insulin Delivery Devices Market is segmented into the Americas, Asia-Pacific, Europe, and Middle East & Africa. Of these, the Americas is foreseen to rule the worldwide insulin delivery devices market inferable from the rising mindfulness about the condition and high social insurance consumption. The area is relied upon to reach USD 21,804.56 million by 2025 at 7.85% CAGR from 2019 to 2025. The Americas represented the biggest provincial market inferable from the developing biotechnology industry, the expanding commonness of diabetes, and a well-created human services segment.
For example, according to the National Diabetes Statistics Report, 2017 distributed by National Center for Chronic Disease Prevention and Health Promotion 30.3 million individuals have diabetes which is 9.4% of the complete populace in the US. These elements are driving the insulin delivery devices market in the Americas. Europe represented the second-biggest market share in 2017 because of broad R&D for medicinal services, expanding subsidizing, and developing appropriation of the innovation inside the area.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Overview:
Ascites is caused due to abnormal
accumulation of fluids in the peritoneal cavity and is mainly triggered by
other disorders such as acute liver failure, liver cirrhosis, cancer,
pancreatic disorders, heart failure, ovarian diseases, hypothyroidism and
others. Market Research Future (MRFR), the global ascites market is anticipated
to expand at a steady CAGR of 4% during the forecast period (2017-2023).
Market Drivers and Restraints:
Increasing alcohol abuse, changing
lifestyles and other factors are leading to the rise in prevalence of liver
cirrhosis which is triggering the incidences of ascites. This rise in ascites
incidences is inducing high demand for effective treatments, leading to the
significant growth of the global ascites
market. Proliferation of cancer patients all over the world and increasing
prevalence of diabetes are some other factors that are driving the expansion of
the global ascites market.
However, complexities regarding the
diagnosis and treatment procedures and low awareness of the disease in the
underdeveloped regions are likely to restrain the expansion of the global
ascites market during the assessment period.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/1909
Key Players:
The prominent players that are profiled by
MRFR in the report on the global ascites market are Sequana Medical, BioVie,
PharmaCyte Biotech Inc., Fresenius SE & Co. KGaA, Medtronic plc, BD, GI
Supply, and others.
Segmental Analysis:
The global ascites market has been segmented
by type, treatment, diagnosis and end user. Based on type, the ascites market
has been segmented into transudative ascites, malignant
ascites and exudate ascites. Based on diagnosis, the ascites market has
been segmented into ultrasound, CT scan, laparoscopy, angiography, and others.
Based on treatment, the ascites market has
been segmented into surgeries and others. The surgeries segment has been
sub-segmented into peritoneovenous shunting, liver transplantation,
transjugular intrahepatic portosystemic shunt (TIPS), and others. Based on end
-users, the ascites market has been segmented into hospital, and clinics,
ambulatory surgical centers, diagnostic centers, and others.
Regional Analysis:
The global ascites market has been
geographically segmented into four major regions such as Europe, Asia Pacific,
the Americas and the Middle East and Africa. The Americas are projecting
dominance over the global ascites market owing to the high prevalence of liver
diseases caused due to increased alcohol consumption and changing lifestyle and
easy adoption of advanced treatment methods in the well-developed healthcare
infrastructure in this region.
The ascites market in the Europe region is
majorly driven by rapid incorporation of advanced technologies in the
healthcare sector, high healthcare expenditure and increased government funding
for research and development of effective treatments in this region. The Asia
Pacific region is growing at fastest rate in the global ascites market due to
increasing awareness regarding ascites and its causative factors and
inclination of population towards getting proper treatment for the disease. The
Middle East and Africa region is anticipated to project steady growth in the
global ascites market owing to the poor primary health care facilities and lack
of awareness in the underdeveloped countries of this region.
Browse Full Report Details @ https://www.marketresearchfuture.com/reports/ascites-market-1909
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
The advancement in diagnostic markers and science has led to the development of the cancer diagnostics market in the forthcoming period. The improvement in reimbursement policies is estimated to support the expansion of the cancer diagnostics market in the impending period.
The surge in cancer diagnoses globally is estimated to fuel the progress of the cancer diagnostics market. The market's report is efficiently analyzed as per MRFR, which provides outlooks for the global markets. By 2025, the market is on track to earn USD 163,000 Million by 2025 with an 8.9% CAGR.
The distinguished companies in the prostate cancer diagnostics market are Arquer Diagnostics Ltd, Illumina, Inc., Becton, Dickinson and Company (BD), BioMark Diagnostics Inc., Biotheranostics, Exact Sciences Corporation, Cancer Diagnostics, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., GE Healthcare, QIAGEN N.V., Roche Diagnostics, Siemens Healthcare, Abbott Laboratories, Inc., and Koninklijke Philips N.V., Inc.
Segmental Analysis
The segmental overview of the cancer diagnostics market is carried out on the basis of type, application, end user and regions. The cancer diagnostics market's application segment comprises breast cancer, colorectal cancer, melanoma cancer, lung cancer, prostate cancer, and liver cancer. The cancer diagnostics market's end user segment comprises hospitals and clinics, diagnostic centers, and research institutes. The region segment of the cancer diagnostics market comprises of the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The type segment of the cancer diagnostics market comprises of biomarkers testing, biopsy, imaging testing, and in-vitro diagnostic testing.
Regional Overview
The regional examination of the cancer diagnostics market comprises of the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The Americas cancer diagnostics market governed the global market due to the mounting elderly inhabitants, the firm healthcare sector, and growing healthcare spending. The European cancer diagnostics market held the second major part of the cancer diagnostics market. The growing awareness about cancer, technological developments in the region, and mounting demand for efficient handling and diagnostics for cancer is anticipated to drive the development of the regional cancer diagnostics market. Germany directed the largest portion in the European market for cancer diagnostics. The Asia-Pacific cancer diagnostics market is anticipated to register the fastest development in the cancer diagnostics market throughout the forecast period owing to the incidence of a large patient collection and snowballing government proposals for the growth of the healthcare sector in the region. Nations in Asia-Pacific are implementing advanced treatment options, which in turn powers the cancer diagnostics market growth in this region.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Throat cancer is a cancer of larynx, vocal chords and other areas of the throat with common symptoms such as cough, sore throat, ear pain, change in voice, difficulty swallowing and others. Market Research Future (MRFR) has published a report stating that the global throat cancer market is anticipated to grow at a significant rate during the forecast period of 2016 to 2022.
Market Drivers and Restraints:
Increasing incidences of throat cancer that are majorly caused due to the addictive habits of smoking, heavy alcohol consumption, betel chewing and others are inducing demand for innovative medications and effective treatments in the global throat cancer market, which in turn is fueling the growth of the global throat cancer market. The rise in geriatric population and widely spreading HPV infections are some other factors that are majorly driving the global throat cancer market.
Market Segmentation:
The global throat cancer market has been segmented on the basis of types and treatments. Based on types, the throat cancer market is segmented into pharyngeal cancer and laryngeal cancer. Based on treatments, the throat cancer market is segmented into surgery, radiation therapy, chemotherapy and others. Among these, the chemotherapy segment is anticipated to account for the major share in the global throat cancer market during the forecast period.
Regional Analysis:
Geographically, the global throat cancer market is segmented into four major regions such as North America, Europe, Asia Pacific and the Middle East and Africa. The North America region is anticipated to expand significantly and project dominance over the global throat cancer market owing to the presence of well-developed healthcare infrastructure, high health care expenditure by the population and presence of prominent players in the global throat cancer market in this region. The throat cancer market in the Europe region is expanding at a noteworthy pace due to the increased research and development activities in the healthcare sector of this region. The high prevalence of throat cancer and increasing awareness regarding the symptoms and available treatments are driving the throat cancer market in the developing economies of the Asia pacific region.
Competitive Analysis:
The players in the global throat cancer market are undergoing strategic alliances, mergers and acquisitions in order to expand their business and dominate the global throat cancer market. The increased research and development expenditure is strengthening the competition in the global throat cancer market.
The leading players profiled by MRFR in the report on the global throat cancer market are Amgen Inc., Bristol-Myers Squibb, Celgene Corporation, Eli Lilly and Company, Engeneic Ltd, F. Hoffmann-la Roche AG, Merck & Co., Inc., Novartis, Pfizer Inc., Teva Pharmaceutical Industries Ltd and Others.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Overview
According to the report by Market Research Future (MRFR), the global health supplements market is expected to surge at a CAGR of 7.8% during the forecast period (2017-2023).
Health supplements are a diverse group of products that consumed for the purpose of supplementing the diet as well as enhancing health. Health supplements typically made up of ingredients derived from natural sources. However they are not meant to prevent, cure, treat, or alleviate the symptoms of medical diseases or conditions.
Drivers and Restraints
One primary factor that the growth of the health supplements market could be chalked up to is the increased marketing toward women by supplement manufacturers. Growing awareness regarding the importance of taking preventative measures related to health, coupled with the increasing size of the aging population worldwide is highly instrumental in the growth of the health supplements market. Also, the continuously growing influence of media advertising about pharmaceuticals along with the significant advancements in the products are are having a tremendous influence on the health supplements market.
Industry Trends
A key trend permeating the market for American health supplements brand is the growing popularity of organic supplements. Organic diets are outpacing regular food at a steady pace, with millennials accounting for a sizeable portion of the consumers across the world. Hence, a number of companies are now focusing on producing more organic certified supplements to gain a competitive advantage in the health supplements market.
Key Players
BASF SE (Germany), E. I. du Pont de Nemours and Company (U.S.), Alticor Inc. (U.S.), The Nature's Bounty Co. (U.S.), Abbott Laboratories (U.S.), Herbalife International (U.S.), GlaxoSmithKline Limited (U.K), Bayer AG (Germany), Glanbia plc (Republic of Ireland), are few of the players in the health supplements market.
Market Segmentation
The global market for health supplements is segmented on the basis of types, application, ingredients and end user.
By type, the market is segmented into dietary supplements, bodybuilding supplements, eye health supplements, specialty supplements, and others. The market for dietary supplements is growing at a health rate due to rising alertness regarding calorie reduction among athletes and gym professionals, promoting the application movement, especially in sports nutrition industry.
By application, the market is segmented into cardiology, rheumatic disorders, allergy, and others.
Regional Analysis
The Americas is leading the global health supplements market backed by the strong presence of major players in the region, who are introducing quality products that capture maximum market share. Also, the government support for research & development along with the availability of funds for research is fostering the health supplements market as well. Countries such as the United States (U.S) and Canada are increasing their investments in the healthcare sector, thereby, propelling the overall growth of the health supplements market in the region.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Market Synopsis:
Ventilator-associated pneumonia is a respiratory disease caused to patients on ventilators. Increasing cases of respiratory diseases are expected to have a positive influence on the growth pattern of the market. According to Market Research Future (MRFR)’s study, the global ventilator-associated pneumonia market is projected to expand at a steady pace over the assessment period 2018 to 2023.
The increasing cases of brain injuries owing to accidents and other hazards are also poised to favor the proliferation of the ventilator-associated pneumonia market over the next couple of years. However, factors such as high ventilator charges, expensive diagnostic tests, risks associated with ventilators, etc. are prognosticated to undermine pace of market growth in the years to come.
Competitive Dashboard:
The noted players of the global ventilator-associated pneumonia market studied in this MRFR report are Adenium Biotech ApS (Denmark), Merck & Co., Inc. (U.S.), AstraZeneca (UK), Nabriva Therapeutics AG (Austria), and MedImmune (US).
Market Segmentation:
By diagnosis, the global ventilator-associated pneumonia market has been segmented into radiological examination, clinical examination, microbiological analysis, and others. The microbiological analysis segment has been further sub-segmented into nonquantitative or semi-quantitative airway sampling, quantitative cultures of airway specimens, and blood and pleural fluid cultures.
On the basis of mode of treatment, the ventilator-associated pneumonia market has been segmented into hospital care, homecare, and others.
Regional Analysis:
The global ventilator-associated pneumonia market, on the basis of region, has been segmented into four key regions, namely Americas, Europe, Asia Pacific, and the Middle East and Africa (MEA). The growth trajectory of the market is expected to be dictated by Americas owing to the presence of a developed healthcare infrastructure coupled with rising healthcare expenditure in North America. The region is also burdened with a huge patient population which is prognosticated to drive the expansion of the ventilator-associated pneumonia market in the region over the next couple of years. Exponential growth in the population of older adults is observed in the recent years. According to the estimations published by the U.S. Census Bureau, Americas will have 19.7 million senior citizens by 2060. This, in turn, is projected to boost the revenue creation of the regional market in the years to come.
Europe is anticipated to stand firm at the second spot in the global market place over the next few years. It has been published by the European respiratory society, that 50% of deaths caused in the region is due to respiratory diseases. Rising cases of respiratory disorders are likely to have a positive influence on the expansion of the ventilator-associated pneumonia market in the forthcoming years. Thus, the regional market’s future trajectory is likely to remain highly lucrative over the next few years.
Market Drivers and Restraints:
Glaucoma is considered to be one of the leading causes of preventable blindness. With the rise in geriatric population, the incidences of glaucoma are increasing resulting in the high demand for surgical treatments, which in turn is fueling the growth of the global glaucoma surgery market.
Increasing inclination towards permanent and faster cure through surgery over long-term use of medication is one of the major drivers of the global glaucoma surgery market. In addition, rise in prevalence of causative disorders such as diabetes and ocular hypertension are inducing need for surgical treatments, leading to the expansion of the global glaucoma surgery market.
However, lack of awareness, preference of non-invasive treatments and high cost associated with the treatment are likely to create hindrance in the growth of the global micro invasive glaucoma surgery market during the forecast period.
Key Players:
The leading players profiled by MRFR in the report on the global glaucoma surgery market are Novartis AG (Switzerland), Allergan (the U.S.), Merck & Co., Inc. (the U.S.), Abbott (the U.S.), Akorn, Inc. (the U.S.), Teva Pharmaceuticals (the U.S.), Bausch & Lomb (the U.S.), Pfizer, Santen (Japan), Carl Zeiss Meditec (Germany), Alcon (the U.S.), Ellex Medical Lasers (Australia), Lumenis (the U.S.), Topcon Medical Systems (the U.S.), Nidek (the U.S.), OPHTEC (the U.S.), Optos (the U.S.), Accutome (the U.S.), AqueSys (Taiwan), Canon (Japan), Essilor (France) and Iridex Corporation (the U.S.)
Market Segmentation:
The global glaucoma surgery market has been segmented on the basis of target, surgery and end-user. Based on target, the glaucoma surgery market is segmented into trabecular meshwork, suprachoroidal space and others. Based on surgery, the glaucoma surgery market is segmented into angle closure glaucoma surgery, aqueous shunt surgery, laser surgery and others. Based on end users, the glaucoma surgery market is segmented into hospital, ambulatory surgery centers and others.
Regional Analysis:
The global glaucoma surgery market is geographically segmented into four major regions such as North America, Asia Pacific, Europe and the Middle East and Africa. The North America region is leading the global glaucoma surgery market with respect to market size. The high number of population suffering from diabetes and other eye disorder and increasing healthcare expenditure are some of the major factors that are fueling the growth of the glaucoma surgery market in this region. The Europe region is registered to be the second largest market for glaucoma surgery owing to the increased research and development for introduction of advanced surgical devices in this region. The Asia Pacific region is projecting significant growth in the global glaucoma surgery market owing to the large population base and increasing prevalence of glaucoma in this region.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
High Throughput Screening (HTS) is an automated drug-discovery process that is typically utilized in the pharmaceutical business. It uses mechanization to identify active compounds, genes, or antibodies in a relatively short time frame. The technique has its use in the initial stages of drug discovery pathway and in toxicology studies.
The high throughput screening market was worth USD 13,460 million in 2018 and is expected to grow at a CAGR of 7.5% during the forecast period.
Market Research Future’s (MRFR) extensive and in-depth study of the global High-Throughput Screening market reveals that it will grow at an impressive rate during the assessment period of 2017-2027. Mounting investments in the healthcare sector and the shifting inclination towards high throughput research is pushing the growth of the market. The HTS market, globally, is largely driven by efficacy & safety screening, target identification & validation, and monitoring of cell-based activity. Some of the additional pointers that would support the growth of the market are the rising drug discovery initiatives by academic and government institutions, huge acceptance of open innovation models by pharmaceutical organizations.
Market Segmentation
The market segmentation of High-throughput Screening is segmented on the following basis: application, product, and end-users.
By application, the market includes Toxicology, Target Identification, Stem Cell Biology, Primary Screening, and others.
By products, the market comprises consumables, software, instruments, and others.
By end-users, the market includes pharmaceutical companies/manufacturers, government organizations, Hospitals and clinics, research facilities, and others
Regional Analysis
The regional market segmentation of High-throughput Screening market is divided into North America, Europe, Asia-Pacific, and the Middle East & Africa.
The North American region is the global geographical market leader of high-throughput screening and is expected to grow at an impressive CAGR of XX% during the forecast period. The demanding R&D initiatives undertaken herein is the major factor that is driving the market growth of this region. High expenditure in healthcare coupled with substantial investments from government and private entities for R& purposes are sure to push the market reach of the North American region.
Europe is the second-largest market and is projected to grow at a substantially fast-paced CAGR percentage during the forecast period. Government support and initiatives are some of the major reasons accelerating the market push of Europe. Additionally, the booming pharmaceutical industry and a resurging economy are further adding fuel to the market potential.
Competitive Analysis
The report also identifies some of the most prominent players in the global High-throughput Screening market, which includes Roche (Switzerland), Agilent Technologies Inc. (US), Beckman Coulter, Inc. (US), Thermo Fisher Scientific, Inc. (US), Life Technologies Corporation (US), Aurora Biomed Inc. (Canada), Bio-Rad Laboratories (US), Luminex Corporation (US), and Sigma-Aldrich Corporation. (US).
Browse Full Report Details @ https://www.marketresearchfuture.com/reports/high-throughput-screening-market-1280
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Drivers and Restraints:
The rapid technological development is playing a crucial role in the expansion of the global e-health services market. The rise in adoption of advanced technology in the healthcare sector is acting as a major driver for the expansion of the global e-health services market. The increasing government initiatives for supporting the use of e-health services in healthcare sector and emergence of curtailing the escalating healthcare costs are attributing factors to the growth of the global e-health services market.
Various regions in the world are facing a shortage of healthcare professionals and high prevalence of chronic diseases, leading to the growing need for e-health services in such regions. The shift in focus of the players of healthcare sector towards providing patient-centric healthcare facilities is fueling the expansion of the global e-health services market. The brisk advancement in technology has led to the increased adoption of cloud computing in the various industrial sectors, including healthcare, which in turn is driving the global e-health services market.
The prominent players of the global e-health services market are IBM Corporation (U.S), Allscripts Healthcare Solutions Inc. (U.S), GE Healthcare (U.S), McKinsey & Co. (U.S), Motion Computing Inc. (U.S), Epocrates Inc. (U.S), Telecare Corp. (U.S), Proteus Digital Health (U.S) Apple (U.S), GE Healthcare (U.S), Boston Scientific Corp (U.S), and Cerner (U.S).
Market Segmentation:
The global e-health services market has been segmented on the basis of type, service, and end-users. By type, the global e-health services market is segmented into electronic health records (EHR), e-prescribing, telemedicine, big data systems, clinical decision support system (CDSS), mobile medical technologies, consumer health IT, and knowledge management system (KMS). By service, the market is segmented into administrative service, clinical service, and financial service. By end-users, the market is segmented into hospitals, clinics, health insurance companies and others.
Detailed Regional Analysis:
The global e-health services market is geographically distributed in for major regions such as Americas, Europe, Asia-Pacific and the Middle East and Africa. Among these regions, the North America region is considered to be the largest market for the e-health services due to the concentration of major players of global e-health services market in this region, the inclination towards the use of software for data management and the presence of well-developed healthcare infrastructure in this region.
The rapid adoption of advanced technology in the healthcare sector of the Europe region has made it the second largest market for the e-health services among other regions of the world. Whereas, the Asia-Pacific region is projecting fastest growth in the global e-health services market owing to the rapid development and adoption of advanced technology by healthcare sector in this region.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
These devices are used in various surgical treatments including kidney stones surgery, prostate surgery and uninary tract surgery among others. The latest report published by Market Research Future (MRFR) projects that the global urology devices market will expand at 7.1% CAGR during the assessment period (2017-2023).
Healthcare expenditure per capita has improved globally, at the same time the ratio of geriatric population continues to grow indifferently, which is also playing an important role is driving the market. Over the years, a wide range of novel medical technologies has arrived in the field of urology. Several groundbreaking minimally invasive surgical procedures have also been developed for treating urological disorders. Such incessant progress has led to development of cutting-edge urology tools. Manufacturers are also focusing on developing and designing organ-specific devices that can better assist surgeons in diagnosing and treating disease in any particular organ in the urinary system.
Global Market for Urology Devices – Competitive Analysis
Some of the prominent market participants profiled in the MRFR’s report include Stryker (US), Olympus Corporation (Japan), Boston Scientific Corporation (US), Cook (US), Dornier MedTech (Germany), NIKKISO CO. LTD (Japan), KARL STORZ GmbH & Co. KG (Germany), HealthTronics, Inc. (US), Medtronic (US), Fresenius Medical Care AG & Co. KGaA (Germany), and C. R. Bard, Inc. (US).
Global Market for Urology Devices – Segmental Analysis
Base on types, the market has been segmented into urinary stone treatment devices, benign prostatic hyperplasia treatment devices, urology dialysis equipment, urinary incontinence & pelvic organ prolapsed devices, endoscopy devices and others. The dialysis equipment segment is further sub-segmented into haemodialysis, peritoneal dialysis and others. The urinary incontinence & pelvic organ prolapsed devices segment is further sub-segment into vaginal meshes & slings, urethral inserts & pessaries, sacral neuromodulator and others. The urinary stone treatment devices segment is further sub-segmented into lithotripsy, ureteral stents and others. The Benign prostatic hyperplasia treatment devices segment in further sub-segmented into catheter ablation, prostatic stents and others. Based on application, the market has been segmented into prostate cancer, urinary incontinence, benign prostatic hyperplasia, urinary stones and others. Based on technology, the market has been segmented into robotic surgery, minimally invasive surgery and others. By end users, the market has been segmented into ambulatory services, hospital and others.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America